SEATTLE, April 30, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today
announced that it will conduct a conference call to discuss its first
quarter 2012 financial results and provide a review of its pipeline of
products in development on Monday, May 7, 2012 at 4:30 p.m. Eastern
To participate in the call by telephone, please dial (877) 280-7291
(United States) or (707) 287-9361 (International). In addition, the
call will be webcast live and can be accessed on the "Events" page of
the "News & Events" section of Oncothyreon's website at www.oncothyreon.com. An archive of the webcast will be available after completion of the
discussion and will be posted on the Oncothyreon website.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.